YORK TIMBER HOLDINGS LIMITED - Voluntary trading statement and trading update
What this filing means
York Timber expects a 41% to 46% decline in EBITDA and a widening core loss per share, though statutory HEPS marginally improved due to non-cash fair value adjustments to biological assets.
York Timber's core business is struggling, making significantly less profit from its actual operations than last year. However, its headline earnings look slightly better on paper because the estimated value of its trees (biological assets) increased.
Bull case
- Cash generated from operations is expected to increase by 127% to 132%, signaling improved liquidity.
- Statutory headline earnings per share (HEPS) are projected to increase by 1.82% to 6.78% despite operational headwinds.
Bear case
- EBITDA (before fair value adjustments) is expected to plunge by 41% to 46%, indicating severe operational pressure.
- Core EPS, which excludes fair value adjustments to biological assets, is widening to a loss of between 6.63 cents and 6.66 cents.
- The figures are unaudited and rely on a restated prior-period base, introducing comparability risks.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
York Timber expects a 41% to 46% decline in EBITDA and a widening Core EPS loss of 6.63 to 6.66 cents, despite a 1.82% to 6.78% increase in statutory HEPS. The stark divergence between HEPS growth and deteriorating EBITDA indicates that profitability is being supported by non-cash fair value adjustments to biological assets, masking underlying operational weakness. These are preliminary, unaudited trading figures based on a recently restated comparative period, not final financial statements. Investor Takeaway: Severe declines in core operational earnings and EBITDA overshadow the modest headline earnings growth, signaling fundamental pressure on the business.
Operational deterioration is clearly evident beneath the statutory headline figures. The reliance on non-cash fair value adjustments warrants caution until the full audited results clarify the accounting restatement impact.
Decision framework
Current stance: Filing Positive
Key drivers
- Cash generated from operations is expected to increase by 127% to 132%, signaling improved liquidity.
- Statutory headline earnings per share (HEPS) are projected to increase by 1.82% to 6.78% despite operational headwinds.
Key risks
- EBITDA (before fair value adjustments) is expected to plunge by 41% to 46%, indicating severe operational pressure.
- Core EPS, which excludes fair value adjustments to biological assets, is widening to a loss of between 6.63 cents and 6.66 cents.
- The figures are unaudited and rely on a restated prior-period base, introducing comparability risks.
What would change the view
- Forward guidance is cut or withdrawn in the next update.
- Cash-flow conversion deteriorates relative to reported earnings.
- Positive thesis fails to hold through the next reporting window.
Evidence from the filing
Cash generated from operations is expected to increase by 127% to 132%, signaling improved liquidity.
“Cash generated from operations is expected to be between 127% and 132% higher than the Previous Comparative Period amount of R45.7 million*.”
Statutory headline earnings per share (HEPS) are projected to increase by 1.82% to 6.78%.
“headline earnings per share ("HEPS") of between 14.57 cents and 15.28 cents, being an increase of between 1.82% and 6.78% when compared to HEPS of 14.31 cents reported for the Previous Comparative Period.”
EBITDA (before fair value adjustments) is expected to plunge by 41% to 46%, indicating severe operational pressure.
“Earnings before interest, taxation, depreciation, amortisation, impairment and fair value adjustments on biological assets is expected to be between 41% and 46% lower than the Previous Comparative Period amount of R84.3 million.”
Core EPS, which excludes fair value adjustments to biological assets, is widening to a loss of between 6.63 cents and 6.66 cents.
“Core EPS (based on the EPS attributable to ordinary shareholders less the fair value adjustment to the biological assets, after taxation) is expected to be a loss per share of between 6.63 cents and 6.66 cents compared to a loss per share of 0.09 cents reported for the Previous Comparative Period.”
The figures are unaudited and rely on a restated prior-period base.
“Shareholders are advised that the information included in this announcement has not been reviewed or reported on by the Company's auditors and is the responsibility of the directors of the Company.”
More on York Timber Holdings Limited
Related filings
More from YRK
- YORK TIMBER HOLDINGS LIMITED - Trading statement and trading update, including notification of the unbundling of certain assets
- YORK TIMBER HOLDINGS LIMITED - Appointment of permanent chief executive officer
- YORK TIMBER HOLDINGS LIMITED - Dealings in securities by a director
- YORK TIMBER HOLDINGS LIMITED - Appointment of interim chief executive officer
- YORK TIMBER HOLDINGS LIMITED - Unaudited condensed consolidated interim financial results for the six months ended 31 December 2025
Other Trading Statement
- INLINVESTEC LIMITED - Investec Group pre-close trading update
- YRKYORK TIMBER HOLDINGS LIMITED - Trading statement and trading update, including notification of the unbundling of certain assets
- EPEEPE CAPITAL PARTNERS LIMITED - Trading statement for the year ended 30 June 2026
- PMRPREMIER GROUP LIMITED - Trading Statement for the six months ending 30 September 2026, Fruit Processing Western Cape and General Share Repurchase Update
- IOCiOCO LIMITED - iOCO Trading Statement